Profiel
Brian R Bond has held positions as President & CEO at Gateway Pharmacology Laboratories LLC and Senior Director-Cardiorenal Pharmacology at Inotiv, Inc.
Actieve functies van Brian R Bond
Bedrijven | Functie | Begin |
---|---|---|
INOTIV, INC. | Corporate Officer/Principal | - |
Gateway Pharmacology Laboratories LLC
Gateway Pharmacology Laboratories LLC Miscellaneous Commercial ServicesCommercial Services Part of Inotiv, Inc., Gateway Pharmacology Laboratories LLC conducts studies to establish proof of concept, define exposure/response relationships, and characterize safety using validated rodent models of pharmacology and disease. Gateway Pharmacology Laboratories is based in Chesterfield, MO. The private company can fully customize and develop new methods and research models to fulfill unique project needs. The company is committed to providing quality and timely results and building productive relationships with their clients. The company specializes in discovery pharmacology for cardiovascular, renal, hepatic, metabolic, and inflammatory diseases, as well as safety pharmacology for blood pressure, heart function, ECG, renal safety, and chronic infusion PK/PD/biomarkers. The CEO of the company is Brian R Bond. The company was acquired by Inotiv, Inc. on August 02, 2021. | Chief Executive Officer | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
INOTIV, INC. | Commercial Services |
Bedrijven in privébezit | 1 |
---|---|
Gateway Pharmacology Laboratories LLC
Gateway Pharmacology Laboratories LLC Miscellaneous Commercial ServicesCommercial Services Part of Inotiv, Inc., Gateway Pharmacology Laboratories LLC conducts studies to establish proof of concept, define exposure/response relationships, and characterize safety using validated rodent models of pharmacology and disease. Gateway Pharmacology Laboratories is based in Chesterfield, MO. The private company can fully customize and develop new methods and research models to fulfill unique project needs. The company is committed to providing quality and timely results and building productive relationships with their clients. The company specializes in discovery pharmacology for cardiovascular, renal, hepatic, metabolic, and inflammatory diseases, as well as safety pharmacology for blood pressure, heart function, ECG, renal safety, and chronic infusion PK/PD/biomarkers. The CEO of the company is Brian R Bond. The company was acquired by Inotiv, Inc. on August 02, 2021. | Commercial Services |